Transfemoral aortic valve implantation for severe aortic stenosis in a patient with dextrocardia situs inversus.

Autor: Good RI; Department of Medicine, Dalhousie University, QE II Health Sciences Center, Halifax, Nova Scotia, Canada., Morgan KP; Department of Medicine, Dalhousie University, QE II Health Sciences Center, Halifax, Nova Scotia, Canada., Brydie A; Department of Medicine, Dalhousie University, QE II Health Sciences Center, Halifax, Nova Scotia, Canada., Beydoun HK; Department of Medicine, Dalhousie University, QE II Health Sciences Center, Halifax, Nova Scotia, Canada., Nadeem SN; Department of Medicine, Dalhousie University, QE II Health Sciences Center, Halifax, Nova Scotia, Canada. Electronic address: najaf.nadeem@cdha.nshealth.ca.
Jazyk: angličtina
Zdroj: The Canadian journal of cardiology [Can J Cardiol] 2014 Sep; Vol. 30 (9), pp. 1108.e1-3. Date of Electronic Publication: 2013 Dec 20.
DOI: 10.1016/j.cjca.2013.12.011
Abstrakt: Transcatheter aortic valve implantation (TAVR) has grown rapidly over the past 10 years. Device and delivery catheter systems have evolved to facilitate the procedure and reduce the risk of associated complications, including those related to vascular access. It is important to understand the utility of the TAVR equipment in patients with more challenging anatomy to select the most appropriate technique for this complex procedure. We report the first case, to our knowledge, of a patient with dextrocardia situs inversus and previous coronary artery bypass grafting who underwent TAVR from the femoral route using the Edwards SAPIEN XT Novaflex+ Transfemoral System (Edwards Lifesciences, Irvine, CA).
(Copyright © 2014 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: